Multimodal Imaging Assessment of the Inflammatory Atheromatous Plaque

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

InflammationAtheromatous PlaquesCarotid Artery Diseases

Interventions

DRUG

68Ga-NODAGA-RGD PET/CT

200 MBq 68 Ga-NODAGA-RGD will be administered i.v. and images centred on the carotid area acquired

Trial Locations (1)

RECRUITING

Centre Hospitalier Universitaire Vaudois, Lausanne

All Listed Sponsors

collaborator

Swiss Heart Foundation

OTHER

lead

University of Lausanne Hospitals

OTHER

NCT01608516 - Multimodal Imaging Assessment of the Inflammatory Atheromatous Plaque | Biotech Hunter | Biotech Hunter